📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy (2024)

First Author: Innes A

Attributed to: Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’ funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-024-02411-7

PubMed Identifier: 39300220

Publication URI: http://europepmc.org/abstract/MED/39300220

Type: Journal Article/Review

Parent Publication: Leukemia

Issue: 11

ISSN: 0887-6924